β-Catenin-mediated c-Myc expression results in the upregulation of several rate-limiting glycolytic genes, including those encoding glucose transporter 1, lactate dehydrogenase, and PKM2, to promote aerobic glycolysis in cancer cells 38. This evidence concerns the gene MYC and cancer.